- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07282366
Video Intervention to Reduce Depression-related Stigma Among Adolescents
Effect of a Video-Based Intervention on Depression-Related Stigma Among Adolescents
Depression-related stigma is a major barrier to help-seeking among adolescents with depression. In China, few interventions specifically target stigma reduction in this population. This study aims to evaluate the effectiveness of a video-based psychoeducational intervention in reducing depression-related stigma and improving help-seeking attitudes among adolescents.
Adolescents aged 8-18 years are recruited from outpatient clinics and schools and screened using the Patient Health Questionnaire-9. Participants are categorized as depressed or non-depressed and randomly assigned into intervention or control groups: depressed adolescents receive a video on personal stigma, non-depressed adolescents receive a video on social stigma, while control groups watch a neutral myopia education video. The study hypothesizes that video-based education can effectively reduce stigma and promote positive help-seeking behaviors among adolescents.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jianjun Ou, doctor
- Phone Number: 17775861486
- Email: oujianjun@csu.edu.cn
Study Locations
-
-
Hunan
-
Changsha, Hunan, China
- Department of Psychiatry, Xiangya Second Hospital, Central South University
-
Contact:
- Jianjun Ou, doctor
- Phone Number: 17775861486
- Email: oujianjun@csu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adolescents aged 8-18 years.
- Able to understand and complete questionnaires in Chinese.
- Normal or corrected-to-normal vision and hearing.
- Have at least a primary school education level.
- Provide written informed consent from both the participant and their parent or guardian.
- For the depressed group: score > 9 on the Patient Health Questionnaire for Adolescents (PHQ-A).
- For the non-depressed group: score ≤ 9 on the PHQ-A.
Exclusion Criteria:
- Presence of severe physical illness or neurological disease (e.g., traumatic brain injury).
- Cognitive impairment, intellectual disability, or significant visual/hearing impairment that prevents participation.
- Current psychotic symptoms or severe psychiatric comorbidities.
- Active suicidal or self-harming behaviors during the study period.
- Failure to comply with study procedures or withdrawal of consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Depressed adolescents - video intervention on personal stigma
|
Participants in this arm are depressed adolescents (PHQ-A >9) who receive a video-based psychoeducational intervention designed to reduce personal stigma toward depression.
The intervention consists of short online videos (approximately 3-5 minutes each) developed by the research team and delivered through a WeChat mini-program.
The videos include animated and narrative content explaining the nature of depression, correcting common misconceptions, and promoting empathy, self-acceptance, and help-seeking attitudes.
The aim is to reduce internalized stigma, improve depression literacy, and encourage professional help-seeking among adolescents with depression.
|
|
Placebo Comparator: Depressed adolescents - control video
|
Participants in this arm watch a neutral health education video that serves as a control condition.
The video, approximately 3-5 minutes in length, focuses on myopia prevention and eye health and contains no content related to mental health or depression.
It is matched in duration and presentation style to the experimental videos to control for exposure time and viewing experience.
The control video is delivered through the same WeChat mini-program platform and viewed once under the supervision of teachers, clinicians, or guardians.
This condition allows for comparison of the specific effects of the depression-related stigma reduction videos with a neutral educational video of a similar format.
|
|
Experimental: Non-depressed adolescents - video intervention on social stigma
|
Participants in this arm are non-depressed (PHQ-A ≤ 9) adolescents who receive a video-based psychoeducational intervention aimed at reducing social stigma toward individuals with depression.
The intervention consists of short online videos (approximately 3-5 minutes each) created by the research team and delivered via a WeChat mini-program.
The videos use engaging animation and real-life narratives to explain the symptoms and causes of depression, challenge negative stereotypes, and promote understanding and acceptance of people experiencing depression.
The goal is to decrease prejudicial attitudes and social distance toward people with depression and to enhance mental health literacy among adolescents.
|
|
Placebo Comparator: Non-depressed adolescents - control video
|
Participants in this arm watch a neutral health education video that serves as a control condition.
The video, approximately 3-5 minutes in length, focuses on myopia prevention and eye health and contains no content related to mental health or depression.
It is matched in duration and presentation style to the experimental videos to control for exposure time and viewing experience.
The control video is delivered through the same WeChat mini-program platform and viewed once under the supervision of teachers, clinicians, or guardians.
This condition allows for comparison of the specific effects of the depression-related stigma reduction videos with a neutral educational video of a similar format.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Stigma Scale
Time Frame: At baseline, immediately post-intervention, and week 8
|
The Depression Stigma Scale is used as the primary outcome measure for participants with a baseline PHQ-A score > 9.
The Depression Stigma Scale is an 18-item self-report measure rated on a 5-point Likert scale.
Total scores range from 0 to 72, with higher scores indicating greater stigma toward depression
|
At baseline, immediately post-intervention, and week 8
|
|
Depression social stigma scale
Time Frame: At baseline, imediately post-intervention, and week 8
|
The Depression Social Stigma Scale is used as the primary outcome measure for participants with a baseline PHQ-A score ≤ 9.
The Depression Social Stigma Scale is an 18-item self-report questionnaire rated on a 4-point Likert scale.
Total scores range from 18 to 72, with higher scores indicating greater social stigma toward depression
|
At baseline, imediately post-intervention, and week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form
Time Frame: At baseline, imediately post-intervention, and week 8
|
The ATSPPH-SF is a 10-item self-report questionnaire scored on a Likert 4-point scale.
Total scores range from 0 to 30, with higher scores indicating more positive attitudes toward seeking professional psychological help.
|
At baseline, imediately post-intervention, and week 8
|
|
General Help-Seeking Questionnaire
Time Frame: At baseline, imediately post-intervention, and week 8
|
The General Help-Seeking Questionnaire assesses intentions to seek help from different sources.
Responses are rated on a 7-point Likert scale.
Total scores range from 18-126, with higher scores indicating greater intention to seek help.
|
At baseline, imediately post-intervention, and week 8
|
|
Depression Literacy Questionnaire
Time Frame: At baseline, imediately post-intervention, and week 8
|
The Depression Literacy Questionnaire is a 22-item self-report measure assessing knowledge about depression.
Total scores range from 0 to 22, with higher scores indicating greater depression literacy.
|
At baseline, imediately post-intervention, and week 8
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program Evaluation Questionnaire
Time Frame: Imediately post-intervention
|
The Program Evaluation Questionnaire is a self-developed questionnaire designed to assess participants' subjective experiences with the video-based depression intervention program.
The questionnaire consists of 5 items covering overall evaluation of the intervention, satisfaction, perceived effectiveness, content preference, and willingness to participate in further feedback interviews.
Items 2 and 3 are rated on 5-point Likert scales assessing satisfaction and agreement, whereas the remaining items are open-ended for qualitative feedback.
Higher scores indicate a more positive evaluation of the intervention.
|
Imediately post-intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LYG20220038
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression - Major Depressive Disorder
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
Cybin IRL LimitedWorldwide Clinical TrialsRecruitingDepression | Major Depressive Disorder (MDD) | Depression - Major Depressive Disorder | Depression in Adults | Depression Disorders | Depression DisorderUnited States, Australia, United Kingdom, Germany, Greece, Poland, Ireland, Czechia
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingMenopausal Depression | Depression - Major Depressive DisorderFrance
-
Jung-Sun LeeSeoul St. Mary's Hospital, The Catholic University; Seoul National University... and other collaboratorsNot yet recruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderSouth Korea
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Francesc Colom, PsyD, PhDHospital del Mar; Instituto de Salud Carlos IIINot yet recruitingDepressive Disorder | Depression Symptoms | Depression - Major Depressive DisorderSpain
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Technical University of MunichEnrolling by invitationMajor Depression Moderate | Major Depression SevereGermany
-
Johns Hopkins UniversityNot yet recruitingMajor Depression | Major Depression Moderate | Major Depression SevereUnited States
Clinical Trials on Video-Based Psychoeducation on Personal Stigma
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingSchizophrenia | Treatment Adherence | Stigma, SocialTurkey
-
Hasan Kalyoncu UniversityCompletedAttention Deficit Hyperactivity DisorderTurkey
-
Recep Tayyip Erdogan UniversityActive, not recruitingKidney Failure, ChronicTurkey
-
Kubra TOHUMCUCompletedBipolar Disorder | Coping SkillsTurkey
-
University of GaziantepCompleted
-
Hatay Training and Research HospitalCompleted
-
Turku University HospitalUniversity of Turku; Tampere University HospitalCompleted
-
Akdeniz UniversityCompletedStress, Psychological | Psychological DistressTurkey
-
Yonsei UniversityCompletedAtrial FibrillationKorea, Republic of
-
Region StockholmCompleted